| - | | use for predicting or treating metastasis of liver cancer using non-coding rna rp11-252e2.2 | 김순선, 은정우, 정재연, 조효정 |
| - | | sfrp4 biomarker as a therapeutic target for hepatocellular carcinoma and use thereof | 김순선, 은정우, 임수빈, 정재연, 조효정 |
| - | | combinations of blood biomarker for diagnosing liver cancer comprising gulp1 and itga6 and use thereof | 김순선, 은정우, 정재연, 조효정 |
| - | | use for diagnosing or predicting prognosis of liver cancer using fibrinogen family | 김순선, 은정우, 정재연, 조효정 |
| - | | novel blood biomarker lactb2, inpp1 and vwa1 for diagnosing liver cancer and use thereof | 김순선, 은정우, 정재연, 조효정 |
| - | | novel blood biomarker cd70 for diagnosing non virus-related hepatocellular carcinoma and use thereof | 김순선, 은정우, 임수빈, 정재연, 조효정 |
| - | | novel blood biomarker sh3pxd2b for diagnosing hepatitis b-related hepatocellular carcinoma and use thereof | 김순선, 은정우, 임수빈, 정재연, 조효정 |
| - | | composition for preventing or treating recurrent liver cancer comprising gulp1 inhibitor | 김순선, 은정우, 정재연, 조효정 |
| - | | use for diagnosing or treating recurrent liver cancer using n6-methyladenosine-modified rp11-108m9.4 | 김순선, 은정우, 정재연, 조효정 |
| - | | method of developing risk score model based on predictive markers to assess likelihood of liver cancer recurrence and liver cancer recurrence prediction system | 김순선, 은정우, 정재연, 조효정 |
| - | | composition for diagnosing liver cancer using methylation status of sort1 gene promoter and uses thereof | 김순선, 은정우, 정재연, 조효정 |
| - | | serum exosomal sf3b4 marker composition for diagnosing early stage hepatocellular carcinoma for noninvasive in vitro diagnosis | 강호철, 김순선, 은정우, 정재연, 조효정 |
| - | | Kit for diagnosis of early liver cancer | 김순선, 은정우, 정재연, 조효정 |
| - | | Method for providing information necessary for diagnosis of early liver cancer | 김순선, 은정우, 정재연, 조효정 |
| - | | Biomarker composition for predicting therapeutic response of severe alcoholic hepatitis and use thereof | 김순선, 은정우, 정재연, 조효정 |
| 2025 | | bacteroides eggerthii kgmb05336 strain and uses thereof | 김순선, 은정우, 정재연, 조효정 |
| 2025 | | novel blood biomarker itga6 for diagnosing liver cancer and use thereof | 김순선, 은정우, 정재연, 조효정 |
| 2024 | | method of screening agents for treating severe alcoholic hepatitis | 김순선, 은정우, 정재연, 조효정 |
| 2023 | | method for providing information for predicting therapeutic response of severe alcoholic hepatitis by rifaximin administration | 김순선, 은정우, 정재연, 조효정 |
| 2023 | | kit for predicting therapeutic response of severe alcoholic hepatitis | 김순선, 은정우, 정재연, 조효정 |
| 2021 | | microRNA biomarker derived exosome for diagnosis of early liver cancer and use thereof | 김순선, 은정우, 정재연, 조효정 |
| 2021 | | SPP1 biomarker for predicting the response of anticancer drugs to liver cancer and use thereof | 김순선, 은정우, 정재연, 조효정 |
| 2021 | | Exosomal miRNA panel marker composition for diagnosing early liver cancer for noninvasive in vitro diagnosis | 김순선, 은정우, 정재연, 조효정 |
| 2021 | | Kit for diagnosing liver cancer comprising an agent capable of measuring expression level of miR-4661-5p | 김순선, 은정우, 정재연, 조효정 |
| 2021 | | Composition for diagnosing liver cancer comprising an agent capable of measuring expression level of miR-4661-5p | 김순선, 은정우, 정재연, 조효정 |
| 2021 | | Method for diagnosing liver cancer by measuring expression level of miR-4661-5p | 김순선, 은정우, 정재연, 조효정 |
| 2021 | | Kit for diagnosing liver cancer comprising an agent capable of measuring expression level of serum exosomal long non-coding RNA | 김순선, 은정우, 정재연, 조효정 |
| 2021 | | Composition for diagnosing liver cancer comprising an agent capable of measuring expression level of serum exosomal long non-coding RNA | 김순선, 은정우, 정재연, 조효정 |
| 2021 | | Method for diagnosing liver cancer by measuring expression level of serum exosomal long non-coding RNA | 김순선, 은정우, 정재연, 조효정 |
| 2021 | | Circulating serum exosomal lncRNA marker composition for diagnosing early liver cancer for noninvasive in vitro diagnosis | 김순선, 은정우, 정재연, 조효정 |
| 2021 | | Composition for early diagnosing hepatocellular carcinoma using WASF2 autoantibody | 강호철, 김소연, 김순선, 은정우, 정재연, 정지민, 조효정 |
| 2020 | | Use for detection of hepatocellular carcinoma specific MLH1 circulating tumor DNA mutation | 김순선, 은정우, 정재연, 조효정 |
| 2019 | | Biomarker for non-invasive in vitro diagnosis of a Hepatocellular carcinoma and biokit for diagnosis thereof comprising the same | 김순선, 은정우, 정재연, 조효정 |
